MedPath

Clinical efficacy study of neoadjuvant therapy with intensity-modulated radiotherapy combined with S-1 for resectable pancreatic cancer

Not Applicable
Recruiting
Conditions
pancreatic cancer
Registration Number
JPRN-UMIN000046456
Lead Sponsor
Kyoto Katsura Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
40
Inclusion Criteria

Not provided

Exclusion Criteria

1.Performance status: 2-4 (according to ECOG criteria) 2.Difficulty in oral intake 3.Severe hepatic or renal impairment 4.Active infectious disease 5.History of radiation therapy for abdominal organs 6.In case the attending physician deems it inappropriate

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
progression free survival for 2 years
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath